Literature DB >> 30374452

The COPD Pipeline XXXVIII.

Nicholas Gross1.   

Abstract

Year:  2018        PMID： 30374452      PMCID： PMC6190519          DOI： 10.15326/jcopdf.5.2.2018.0136

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN： 2372-952X


× No keyword cloud information.
  5 in total

1.  Tezepelumab in Adults with Uncontrolled Asthma.

Authors:  Jonathan Corren; Jane R Parnes; Liangwei Wang; May Mo; Stephanie L Roseti; Janet M Griffiths; René van der Merwe
Journal:  N Engl J Med       Date:  2017-09-07       Impact factor: 91.245

2.  CHF6001 II: a novel phosphodiesterase 4 inhibitor, suitable for topical pulmonary administration--in vivo preclinical pharmacology profile defines a potent anti-inflammatory compound with a wide therapeutic window.

Authors:  Gino Villetti; Chiara Carnini; Loredana Battipaglia; Laurent Preynat; Pier Tonino Bolzoni; Franco Bassani; Paola Caruso; Marco Bergamaschi; Anna Rita Pisano; Veronica Puviani; Fabio Franco Stellari; Valentina Cenacchi; Roberta Volta; Vittorio Bertacche; Valentina Mileo; Valentina Bagnacani; Elisa Moretti; Paola Puccini; Silvia Catinella; Fabrizio Facchinetti; Angelo Sala; Maurizio Civelli
Journal:  J Pharmacol Exp Ther       Date:  2015-01-09       Impact factor: 4.030

Review 3.  Novel Endoscopic Approaches to Treating Chronic Obstructive Pulmonary Disease and Emphysema.

Authors:  D Gompelmann; R Eberhardt; F J F Herth
Journal:  Semin Respir Crit Care Med       Date:  2015-08-03       Impact factor: 3.119

Review 4.  The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review.

Authors:  Xiang Tong; Dongguang Wang; Sitong Liu; Yao Ma; Zhenzhen Li; Panwen Tian; Hong Fan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-30

Review 5.  Doxofylline is not just another theophylline!

Authors:  Maria Gabriella Matera; Clive Page; Mario Cazzola
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.